345 related articles for article (PubMed ID: 7153988)
1. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
Hall RE; Muchmore AV; Blaese RM
J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous cytotoxicity. III. Inhibition of human monocyte mediated cytotoxicity by pokeweed mitogen.
Muchmore AV; Decker JM; Blaese RM
J Immunol; 1979 Jan; 122(1):61-4. PubMed ID: 762423
[TBL] [Abstract][Full Text] [Related]
3. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
Scornik JC; Ruiz P; Hoffman EM
J Immunol; 1979 Sep; 123(3):1278-84. PubMed ID: 469250
[TBL] [Abstract][Full Text] [Related]
4. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
Cortens M; Sklar S; Richter M
Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
[TBL] [Abstract][Full Text] [Related]
5. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
6. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of surface FcRI and decrease in antibody-dependent cellular cytotoxicity of cultured monocytes. Reversal by monensin or cytochalasin-D.
Tripathi AK; Taplits M; Puri J; Hoffman T
J Immunol; 1991 Feb; 146(4):1309-15. PubMed ID: 1991969
[TBL] [Abstract][Full Text] [Related]
8. Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.
Shaw GM; Levy PC; LoBuglio AF
J Clin Invest; 1978 Dec; 62(6):1172-80. PubMed ID: 748372
[TBL] [Abstract][Full Text] [Related]
9. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro.
Norris DA; Ryan SB; Kissinger RM; Fritz KA; Boyce ST
J Immunol; 1985 Aug; 135(2):1073-9. PubMed ID: 2409136
[TBL] [Abstract][Full Text] [Related]
10. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
11. The role of reactive oxygen intermediates in nonspecific monocyte cytotoxicity induced by immune complexes.
Geffner JR; Giordano M; Serebrinsky G; Isturiz M
Clin Exp Immunol; 1987 Mar; 67(3):646-54. PubMed ID: 3038442
[TBL] [Abstract][Full Text] [Related]
12. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
Mavier P; Edgington TS
J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594
[TBL] [Abstract][Full Text] [Related]
13. Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity.
Shaw GM; Levy PC; Lobuglio AF
J Immunol; 1978 Aug; 121(2):573-8. PubMed ID: 79607
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
15. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
16. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
17. Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.
Weiner LM; Steplewski Z; Koprowski H; Litwin S; Comis RL
Cancer Res; 1988 Feb; 48(4):1042-6. PubMed ID: 3123051
[TBL] [Abstract][Full Text] [Related]
18. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
Richter M; Kazaniwsky N
Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
[TBL] [Abstract][Full Text] [Related]
19. The role of cyclosporin A on antibody-dependent monocyte-mediated cytotoxicity against human multidrug-resistant cancer cells.
Yano S; Yanagawa H; Hanibuchi M; Pai K; Nishioka Y; Tsuruo T; Sone S
J Med Invest; 1998 Feb; 44(3-4):185-91. PubMed ID: 9597807
[TBL] [Abstract][Full Text] [Related]
20. Human lymphoblastoid cell lines as effector cells in mitogen-dependent and antibody-dependent cell-mediated lysis.
Jordan TF; Ferrone S; Pellegrino MA; Dennert G
Cancer Res; 1978 Nov; 38(11 Pt 1):3707-11. PubMed ID: 698930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
